Log in to save to my catalogue

Inflammatory endothelium-targeted and cathepsin responsive nanoparticles are effective against ather...

Inflammatory endothelium-targeted and cathepsin responsive nanoparticles are effective against ather...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9169363

Inflammatory endothelium-targeted and cathepsin responsive nanoparticles are effective against atherosclerosis

About this item

Full title

Inflammatory endothelium-targeted and cathepsin responsive nanoparticles are effective against atherosclerosis

Publisher

Australia: Ivyspring International Publisher Pty Ltd

Journal title

Theranostics, 2022-01, Vol.12 (9), p.4200-4220

Language

English

Formats

Publication information

Publisher

Australia: Ivyspring International Publisher Pty Ltd

More information

Scope and Contents

Contents

Atherosclerosis is characterized by lipid accumulation, plaque formation, and artery stenosis. The pharmacological treatment is a promising therapy for atherosclerosis, but this approach faces major challenges such as targeted drug delivery, controlled release, and non-specific clearance.
Based on the finding that the cathepsin k (CTSK) enzyme i...

Alternative Titles

Full title

Inflammatory endothelium-targeted and cathepsin responsive nanoparticles are effective against atherosclerosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9169363

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9169363

Other Identifiers

ISSN

1838-7640

E-ISSN

1838-7640

DOI

10.7150/thno.70896

How to access this item